Fluticasone chemical structure
Find information on thousands of medical conditions and prescription drugs.

Fluticasone

Fluticasone proprionate is a glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide® and Flixonase® by Allen & Hanburys and Flovent® and Flonase® by GlaxoSmithKline. more...

Home
Diseases
Medicines
A
B
C
D
E
F
Captagon
Famohexal
Famotidine
Faslodex
Faslodex
Fasoracetam
Felbamate
Felbatol
Felodipine
Felypressin
Femara
Femara
Fempatch
Femring
Fenfluramine
Fenofibrate
Fentanyl
Fexofenadine
Filgrastim
Filipin
Finasteride
Fioricet
Fiorinal
Flagyl
Flarex
Flavoxate
Flecainide
Flexeril
Flomax
Flonase
Flovent
Floxuridine
Fluacizine
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine
Fludrocortisone
Flumazenil
Flunisolide
Flunitrazepam
Fluocinonide
Fluohexal
Fluorometholone
Fluorouracil
Fluoxetine
Fluphenazine
Flurazepam
Flutamide
Fluticasone
Fluvastatin
Fluvoxamine
FML
Focalin
Folic acid
Follutein
Fomepizole
Formoterol
Fortamet
Fortovase
Fosamax
Fosinopril
Fosinoprilat
Fosmidomycin
Fosphenytoin
Frova
Frovatriptan
Frusehexal
Fulvestrant
Fumagillin
Furazolidone
Furosemide
Furoxone
Fusafungine
Fusidic acid
Fuzeon
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

How it works

The precise mechanisms of glucocorticoid action in asthma are unknown. Inflammation is recognized as an important component in the pathogenesis of asthma. Glucocorticoids have been shown to inhibit multiple cell types (e.g., mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils) and mediator production or secretion (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in the asthmatic response. These anti-inflammatory actions of glucocorticoids may contribute to their efficacy in asthma. Typically, however, the action on the cells affected requires several days. Therefore, inhaled steroids are not used for immediate relief of asthma, but instead as preventive and maintenance therapy.

Clinical trials

This listing is NOT complete and should NOT be construed as support for treatment decisions. See also PubMed clinical manuscripts referring to fluticasone

  • Burge, P.S.; Calverley, P.M.; Jones, P.W.; Spencer, S.; Anderson, J.A.; and Maslen T.K. (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. British Medical Journal 320 (7245), 1297-1303. PMID 10807619.
  • Paggiaro, P.L.; Dahle, R.; Bakran, I.; Frith, L.; Hollingworth, K.; and Efthimiou, J. (1998). Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. The Lancet 351 (9105), 773-780. PMID 9519948.
both support a positive outcome for use of fluticasone in patients with chronic obstructive pulmonary disease, also referred to as COPD

Read more at Wikipedia.org


[List your site here Free!]


Montelukast outcomes appear to rival fluticasone: persistent asthma.(Clinical Rounds) : An article from: Family Practice News $5.95 Steroid comparison studies needed for AD. (Which Works Best?).(atopic dermatitis) : An article from: Skin & Allergy News $5.95
Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopic dermatitis with clinical suspicion ... of Dermatology, Venereology and Leprology $5.95

Clinical efficacy of aerosolized fluticasone therapy in the early management of acute moderate exacerbations of asthma by PMDI and zero stat 'V' spacer
PURPOSE: To assess the utility of inhaled corticosteroids for the early management of acute exacerbations of asthma in the emergency room. METHODS: ...
Effect of fluticasone propionate/salmeterol 250/50 on lung hyperinflation and exercise endurance in patients with COPD
PURPOSE: To evaluate the effect of fluticasone propionate (FP)/ salmeterol Diskus (FSC) 250/50 BID and placebo (PLA) on lung hyperinflation and exercise ...
Control of airway inflammation is achieved in asthma patients with fluticasone propionate alone: adding montelukast provides no additional control of airway
PURPOSE: This randomized, double-blind study evaluated airway inflammation following administration of fluticasone propionate (FP) 100mcg BID or FP 100mcg BID + montelukast (MON) 10mg QD for 12 wee
Salmeterol-fluticasone vs. fluticasone alone for asthma
Clinical Question: Is guideline-driven care of patients with asthma using stepwise increases in salmeterol-fluticasone therapy more effective than using ...
Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma
Background: Inhaled corticosteroids (ICSs) are an effective treatment of asthma even when administered at a low dose. Once asthma is controlled, current ...
Efficacy of inhaled fluticasone plus salmeterol in COPD
Chronic obstructive pulmonary disease (COPD), which is characterized by airflow limitation that is not fully reversible, affects a significant portion ...
The effect of topical fluticasone on nasal nitric oxide levels in a patient with allergic rhinitis - Original Article
Abstract Nitric oxide (NO) in exhaled breath is produced primarily by the upper respiratory airway mucosa. The nasal output of this gas is increased ...
Fluticasone-associated cutaneous allergic granulomatous vasculitis - Case Reports
Introduction: Churg-Strauss syndrome (CSS) is a multisystem vasculitis of unknown etiology first described in 1951 using autopsy specimens from patients ...

Home Contact Resources Exchange Links ebay